Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleOncology

18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods

Joan Fledelius, Anne Winther-Larsen, Azza A. Khalil, Catharina M. Bylov, Karin Hjorthaug, Aksel Bertelsen, Jørgen Frøkiær and Peter Meldgaard
Journal of Nuclear Medicine December 2017, 58 (12) 1931-1937; DOI: https://doi.org/10.2967/jnumed.117.193003
Joan Fledelius
1Department of Nuclear Medicine, Herning Regional Hospital, Herning, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Winther-Larsen
2Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azza A. Khalil
3Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catharina M. Bylov
4Department of Radiology, Aarhus University Hospital, Aarhus, Denmark; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Hjorthaug
5Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aksel Bertelsen
1Department of Nuclear Medicine, Herning Regional Hospital, Herning, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jørgen Frøkiær
5Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Meldgaard
3Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 12 1931-1937
DOI 
https://doi.org/10.2967/jnumed.117.193003
PubMed 
28490472

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication March 20, 2017
  • Accepted for publication April 25, 2017
  • Published online December 1, 2017.

Article Versions

  • previous version (May 10, 2017 - 13:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Joan Fledelius1,
  2. Anne Winther-Larsen2,
  3. Azza A. Khalil3,
  4. Catharina M. Bylov4,
  5. Karin Hjorthaug5,
  6. Aksel Bertelsen1,
  7. Jørgen Frøkiær5 and
  8. Peter Meldgaard3
  1. 1Department of Nuclear Medicine, Herning Regional Hospital, Herning, Denmark
  2. 2Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
  3. 3Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  4. 4Department of Radiology, Aarhus University Hospital, Aarhus, Denmark; and
  5. 5Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark
  1. For correspondence or reprints contact: Joan Fledelius, Department of Nuclear Medicine, Herning Regional Hospital, DK-7400 Herning, Denmark. E-mail: joan.fledelius{at}rm.dk
View Full Text

Statistics from Altmetric.com

Cited By...

  • 16 Citations
  • 13 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Molecular and functional imaging in cancer-targeted therapy: current applications and future directions
    Jing-Wen Bai, Si-Qi Qiu, Guo-Jun Zhang
    Signal Transduction and Targeted Therapy 2023 8 1
  • What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
    Guy-Anne Turgeon, Amir Iravani, Tim Akhurst, Alexis Beaulieu, Jason W. Callahan, Mathias Bressel, Aidan J. Cole, Sarah J. Everitt, Shankar Siva, Rodney J. Hicks, David L. Ball, Michael P. Mac Manus
    Journal of Nuclear Medicine 2019 60 3
  • Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer
    Jeong Won Lee, Ho Sung Lee, Ju Ock Na, Sang Mi Lee
    Clinical Imaging 2018 50
  • Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST
    Takayuki Katsuura, Kazuhiro Kitajima, Masayuki Fujiwara, Tomonori Terada, Nobuhiro Uwa, Kazuma Noguchi, Hiroshi Doi, Yukihisa Tamaki, Rika Yoshida, Tatsuya Tsuchitani, Masahiro Fujita, Koichiro Yamakado
    Annals of Nuclear Medicine 2018 32 7
  • Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study
    Akihiko Takeuchi, Makoto Endo, Akira Kawai, Yoshihiro Nishida, Ryu Terauchi, Akihiko Matsumine, Hisaki Aiba, Tomoki Nakamura, Susumu Tandai, Toshifumi Ozaki, Manabu Hoshi, Daiki Kayano, Miho Okuda, Norio Yamamoto, Katsuhiro Hayashi, Shinji Miwa, Kentaro Igarashi, Kenichi Yoshimura, Akihiro Nomura, Toshinori Murayama, Hiroyuki Tsuchiya
    Frontiers in Oncology 2022 12
  • 18F-FDG PET/CT for assessing heterogeneous metabolic response between primary tumor and metastases and prognosis in non-small cell lung cancer
    Lirao Peng, Bulin Du, Yan Cui, Qiu Luan, Yaming Li, Xuena Li
    Clinical Lung Cancer 2022 23 7
  • 18F-Fluorodeoxyglucose PET/CT for Early Prediction of Outcomes in Patients with Advanced Lung Adenocarcinomas and EGFR Mutations Treated with First-Line EGFR-TKIs
    Yu-Erh Huang, Ying-Huang Tsai, Yu-Jie Huang, Jr-Hau Lung, Kuo-Wei Ho, Tzu-Chen Yen, Sheng-Chieh Chan, Shu-Tian Chen, Ming-Feng Tsai, Ming-Szu Hung
    Cancers 2022 14 6
  • A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients With Non-Small Cell Lung Cancer
    Wenfang Tang, Qingyi Hou, Juntao Lin, Dongjiang Li, Jieshan Lin, Jinghua Chen, Zhenbin Qiu, Xiangpeng Chu, Xiongwen Yang, Honghong Yan, Shuxia Wang, Yilong Wu, Wenzhao Zhong
    Frontiers in Oncology 2020 10
  • Establishment of a [18F]-FDG-PET/MRI Imaging Protocol for Gastric Cancer PDX as a Preclinical Research Tool
    Seong-Woo Bae, Felix Berlth, Kyoung-Yun Jeong, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Woo Ho Kim, June-Key Chung, Han-Kwang Yang
    Journal of Gastric Cancer 2020 20 1
  • Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC
    Alessandro Leonetti, Veronica Cervati, Roberta Minari, Maura Scarlattei, Michela Verzè, Marianna Peroni, Monica Pluchino, Francesco Bonatti, Fabiana Perrone, Giulia Mazzaschi, Agnese Cosenza, Letizia Gnetti, Paola Bordi, Livia Ruffini, Marcello Tiseo
    Clinical Lung Cancer 2024 25 8

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017383040
Jun 2017170015
Jul 2017120014
Aug 201745031
Sep 201768013
Oct 201761012
Nov 201741019
Dec 201712311786
Jan 2018298417
Feb 201811139
Mar 201811459
Apr 201869119
May 201845412
Jun 2018531514
Jul 20182888
Aug 2018281410
Sep 201832157
Oct 2018242720
Nov 2018232011
Dec 2018232615
Jan 201925188
Feb 2019232213
Mar 2019232814
Apr 2019181315
May 201922815
Jun 20191238
Jul 20192288
Aug 201981612
Sep 201917812
Oct 201916218
Nov 201919814
Dec 201912212
Jan 2020121013
Feb 2020836
Mar 202011117
Apr 20207811
May 202018516
Jun 202019713
Jul 202015613
Aug 2020432
Sep 2020622
Oct 20201068
Nov 202011413
Dec 20209610
Jan 202121414
Feb 20215106
Mar 20211178
Apr 202121811
May 20214207
Jun 20214142
Jul 202181219
Aug 20215149
Sep 202121210
Oct 202141525
Nov 202121722
Dec 2021102111
Jan 2022131815
Feb 202210117
Mar 202221413
Apr 202221713
May 202261420
Jun 20221912
Jul 20222202
Aug 202231112
Sep 202241115
Oct 202211011
Nov 20222911
Dec 20223157
Jan 202332511
Feb 2023273
Mar 202342112
Apr 2023327
May 2023265
Jun 202332811
Jul 20231146
Aug 2023385
Sep 20231163
Oct 2023368
Nov 20232146
Dec 20230222
Jan 20243196
Feb 20240158
Mar 2024172
Apr 202466812
May 20240269
Jun 20243187
Jul 202491810
Aug 202432915
Sep 20243319
Oct 2024102210
Nov 202481310
Dec 20242128
Jan 20253148
Feb 20251447
Mar 202543620
Apr 2025102626
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (12)
Journal of Nuclear Medicine
Vol. 58, Issue 12
December 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
Joan Fledelius, Anne Winther-Larsen, Azza A. Khalil, Catharina M. Bylov, Karin Hjorthaug, Aksel Bertelsen, Jørgen Frøkiær, Peter Meldgaard
Journal of Nuclear Medicine Dec 2017, 58 (12) 1931-1937; DOI: 10.2967/jnumed.117.193003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
Joan Fledelius, Anne Winther-Larsen, Azza A. Khalil, Catharina M. Bylov, Karin Hjorthaug, Aksel Bertelsen, Jørgen Frøkiær, Peter Meldgaard
Journal of Nuclear Medicine Dec 2017, 58 (12) 1931-1937; DOI: 10.2967/jnumed.117.193003
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
  • Google Scholar

More in this TOC Section

Oncology

  • Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
  • Metastatic NUT Midline Carcinoma
  • Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100
Show more Oncology

Clinical

  • Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
  • Metastatic NUT Midline Carcinoma
  • Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100
Show more Clinical

Similar Articles

Keywords

  • FDG PET/CT
  • lung cancer
  • PERCIST 1.0
  • early response evaluation
  • TLG
SNMMI

© 2025 SNMMI

Powered by HighWire